MG
EOLS icon

Michael Gelband’s Evolus EOLS Stock Holding History

Michael Gelband’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-51,700
Closed -$173K – 2234
2020
Q4 		$173K Buy
+51,700
New +$194K ﹤0.01% 1763

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Michael Gelband's EOLS Position: Q2 2026 in Review

Michael Gelband opened a new position in Evolus (EOLS) in Q2 2026: 76,997 shares worth $534K. The stake represents ﹤0.01% of the portfolio and ranks #1225 among its holdings. This is a return to the name: Michael Gelband previously reported a position in EOLS as recently as Q4 2025.

Michael Gelband first reported a position in EOLS in Q2 2019 and has held it in 15 quarters since. The position peaked at $3.98M in Q1 2023. 157 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Michael Gelband held 76,997 shares of Evolus worth $534K as of Q2 2026.
  • Evolus was a new Michael Gelband position in Q2 2026.
  • Evolus made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1225 holding.
  • Michael Gelband first reported a position in Evolus in Q2 2019 and has held it in 15 quarters since.
  • Michael Gelband's Evolus position peaked at $3.98M in Q1 2023.
  • 157 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.